, Singapore

Daily Markets Briefing: STI down 0.9%

Index likely to see a technical rebound today.

According to OCBC Investment Research:

The modest rebound on Wall Street overnight could provide some relief for the local bourse this morning, especially after the STI’s 0.9% tumble yesterday (index was down as much as 1.9% during the session).

While the index is likely to see a technical rebound today, inching higher towards the 3370 gap resistance, overall tone could remain cautious ahead of the weekend.

Above that, the next resistance lies at the 3410 minor peak. On the downside, the immediate resistance is pegged at the 3320 key resistance-turned-support, with the subsequent base marked at the 3303 level (yesterday’s intraday low).

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Top News

AI growth stalls as 78% cite weak data infrastructure
Confluent said firms are prioritising data streaming as they move AI projects from pilots into production.
Singapore emerges as key hub in Asia-Pacific’s next medtech wave
The city-state’s regulatory strength helps translate medical innovations into globally validated products.
Healthcare